Sculptor Capital’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,582
Closed -$7M 1241
2021
Q4
$7M Sell
18,582
-21,688
-54% -$8.43M 0.06% 283
2021
Q3
$16.6M Sell
40,270
-23,474
-37% -$9.75M 0.14% 104
2021
Q2
$23.6M Sell
63,744
-15,914
-20% -$5.31M 0.17% 89
2021
Q1
$23.1M Sell
79,658
-99,496
-56% -$27.7M 0.19% 82
2020
Q4
$44.8M Sell
179,154
-168,949
-49% -$40.2M 0.19% 60
2020
Q3
$78.8M Sell
348,103
-64,823
-16% -$13.5M 0.5% 33
2020
Q2
$72M Sell
412,926
-47,542
-10% -$7.59M 0.61% 34
2020
Q1
$58.1M Buy
460,468
+882
+0.2% +$132K 0.82% 25
2019
Q4
$70.2M Buy
459,586
+22,500
+5% +$3.12M 0.74% 30
2019
Q3
$57.9M Buy
437,086
+54,340
+14% +$7.29M 0.62% 38
2019
Q2
$54.3M Buy
382,746
+77,700
+25% +$10.5M 0.29% 51
2019
Q1
$44.3M Buy
+305,046
New +$40.1M 0.26% 48

Other funds holding CRL